Chemical Abortion Risk Awareness Act

# Chemical Abortion Risk Awareness Act (HR 7237) Summary **What the Bill Would Do** This bill, introduced by Rep. Marlin Stutzman (R-IN), would require healthcare providers to inform patients about risks associated with medication abortion (also called chemical or pill-based abortion) before the procedure. The bill aims to establish informed consent requirements for patients seeking this type of abortion using medications like mifepristone and misoprostol. **Who It Affects and Key Provisions** The bill would primarily affect women seeking medication abortion and the healthcare providers who administer it.

While specific provisions aren't detailed in the available information, similar bills typically require doctors to provide written information about potential risks and complications, and may include waiting periods before the procedure can occur. Supporters argue such requirements ensure informed decision-making, while opponents contend they add unnecessary barriers to accessing abortion care. **Current Status** As of now, HR 7237 remains in committee and has not been voted on by the full House. The bill is part of broader legislative efforts regarding abortion policy in the current Congress.